The selection of patients for PSMA radiopharmaceutical therapy is improved by a newly developed PSG score.

Published Date: 26 Apr 2023

The effectiveness of 177Lu-PSMA therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) can be accurately predicted using a recently developed PSMA PET scoring system. international, multicenter testing.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer

2.

Higher Binge Drinking Rates Linked to New Cannabis Laws.

3.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

4.

Ketamine plus psychotherapy for "excellent" PTSD

5.

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot